首页> 外文OA文献 >Structural basis of Ribosomal S6 Kinase 1 (RSK1) inhibition by S100B Protein: modulation of the Extracellular Signal-regulated Kinase (ERK) signaling cascade in a calcium-dependent way.
【2h】

Structural basis of Ribosomal S6 Kinase 1 (RSK1) inhibition by S100B Protein: modulation of the Extracellular Signal-regulated Kinase (ERK) signaling cascade in a calcium-dependent way.

机译:S100B蛋白抑制核糖体S6激酶1(RSK1)的结构基础:以钙依赖的方式调节细胞外信号调节激酶(ERK)信号级联。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mitogen-activated protein kinases (MAPK) promote MAPK activated protein kinase (MAPKAPK) activation. In the MAPK pathway responsible to cell growth, ERK2 initiates the first phosphorylation event on RSK1, which is inhibited by calcium-binding S100 proteins in malignant melanomas. Here we present a detailed in vitro biochemical and structural characterization of the S100B-RSK1 interaction. The calcium-dependent binding of S100B to the calcium/calmodulin dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent to the better known binding of calmodulin to CaMKII. Although S100B-RSK1 and the calmodulin-CAMKII system are clearly distinct functionally, they demonstrate how unrelated intracellular Ca2+ binding proteins could influence the activity of CaMK domain containing protein kinases. Our crystallographic, small angle X-ray scattering (SAXS) and NMR analysis revealed that S100B forms a ''fuzzy'' complex with RSK1 peptide ligands. Based on fast-kinetics experiments we conclude that the binding involves both conformation selection and induced fit steps. Knowledge of the structural basis of this interaction could facilitate therapeutic targeting of melanomas.
机译:丝裂原激活的蛋白激酶(MAPK)促进MAPK激活的蛋白激酶(MAPKAPK)激活。在负责细胞生长的MAPK途径中,ERK2启动RSK1上的第一个磷酸化事件,该事件被恶性黑色素瘤中钙结合性S100蛋白抑制。在这里,我们介绍了S100B-RSK1相互作用的详细的体外生化和结构表征。 S100B与钙/钙调蛋白依赖性蛋白激酶(CaMK)型结构域的钙依赖性结合使人联想到钙调蛋白与CaMKII的结合。尽管S100B-RSK1和钙调蛋白-CAMKII系统在功能上明显不同,但它们表明无关的细胞内Ca2 +结合蛋白如何影响含CaMK域的蛋白激酶的活性。我们的晶体学,小角X射线散射(SAXS)和NMR分析表明,S100B与RSK1肽配体形成“模糊”复合物。基于快速动力学实验,我们得出结论,该结合涉及构象选择和诱导拟合步骤。了解这种相互作用的结构基础可以促进黑色素瘤的治疗靶向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号